Form 10-K Minerva Neurosciences, For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Nasdaq ends lower with tech; investors assess softer jobs data
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Whirlpool to close Mexico plant, expects $165M restructuring cost
- Meta Platforms stock surges 8% on cloud business plans
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Wall Street ends choppy session lower as tech shares drop
Minerva Neurosciences (NERV) Misses Q4 EPS by 3c
March 14, 2016 7:32 AM EDTMinerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($0.34), $0.03 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.
... More